The experimental weight loss drug retatrutide could also help to improve liver health, a new study suggests. The findings came from a large clinical trial led by Virginia Commonwealth University (VCU), which included obese participants with fatty liver disease. Researchers found that the injectable drug decreased fat in people’s livers …
Read More »
A genetic test could predict whether a child will be obese as an adult. A global study, published in the journal Nature Medicine, found that the risk of severe obesity in adulthood can be identified in early childhood through a polygenic risk score (PGS). The PGS acts as a “calculator” …
Read More »
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as …
Read More »
Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with medical imaging, such as PET and CT (“CAT”) scans. CT scans are often used to get detailed internal images to detect …
Read More »
Amy Schumer isn’t hiding behind filters. The 44-year-old comedian showed off her flat abs in a mirror selfie this week, rocking a sports bra and dark-colored pants while keeping things candid with her fans. Her social media caption read, “No filter, no filler, no clean mirror.” In the photo, Schumer …
Read More »